• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Enforcement Report - Week of June 19, 2024

    FDA

    Alembic`s Generic Bromfenac Receives Approval in the U.S.

    FDA

    Lupin gets USFDA nod for Bromfenac Ophthalmic Solution

    ECONOMIC TIMES

    Eugia`s Generic Bromfenac Receives Approval in the U.S.

    FDA

    Enforcement Report for Week of February 20, 2019

    FDA

    Enforcement Report - Week of February 6, 2019

    FDA

    Prolensa (Bromfenac) : Senju Pharmaceutical, B&L vs. Amneal Pharmaceuticals

    PATENT LITIGATION

    Sun Pharma rises with R&D and bets on specialty drugs

    ECONOMIC TIMES

    Prolensa®(bromfenac): Senju Pharmaceutical v. Amneal Pharmaceuticals

    PATENT LITIGATION

    Perrigo gets tentative approval for generic Prolensa

    DRUG STORE NEWS

    How Top Indian Drug Makers Like Sun, Glenmark are Building Business in the US

    ECONOMIC TIMES

    Sun Pharma Launches First Branded Drug BromSite in US

    ECONOMIC TIMES

    Mayne Pharma USA Recalls Bromfenac Ophthalmic Sol 0.09% due to Lack of Sterility

    FDA

    Valeant Announces New U.S. Fulfillment Agreements With Walgreens

    PR NEWS WIRE

    Apotex recalls Bromfenac Ophthalmic Sol due to Lack of Assurance of Sterility

    FDA

    Sun Pharma bids to acquire InSite Vision Inc

    THE ECONOMIC TIMES

    Bausch & Lomb, Inc. recalls Bromfenac Ophthalmic Solution, 0.09% due to Lack of Assurance of Sterility

    FDA

    Apotex Inc., Ongoing Class III recall of Bromfenac Ophthalmic Solution 0.09%, Rx Only. Mfg For: Apotex Corp., Weston, FL, 33326. Available in a) 1.7 mL Bottle, NDC: 60505-0595-5; b) 2 x 1.7 mL Bottles, NDC: 60505-0595-6; c) 2.5 mL Bottles, NDC: 60505-0596-4. because of CGMP Deviations: Product excipient was not re-tested at the appropriate date.

    FDA

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.